BioNTech
BioNTech was founded by scientists and physicians to translate science into survival by combining fundamental research and operational excellence. We at BioNTech believe that the immune system is the fundamental driver for therapeutic success in cancer, and infectious diseases and other serious diseases.
BioNTech - Wikipedia
BioNTech SE (/ biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek[3] short for Biopharmaceutical New Technologies) is a global biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Newsroom - BioNTech
Videos, photos, press releases or data sheets Learn more about BioNTech! Here you can find all media data in an overview for download. Investors Healthcare Professionals Newsroom Clinical Trials
BioNTech | Technologies for customized treatment approaches
Based on our modular multi-platform approach we harness breakthrough technologies across different drug classes and modalities to create tailored treatment approaches for oncology and infectious diseases ushering in a new era of immunotherapies.
BioNTech Provides Business and Pipeline Updates at 43rd
3 days ago · BioNTech aims to develop BNT327/PM8002 as a next-generation immuno-oncology (“IO”) backbone for the Company’s combination strategy targeting a broad range of indications;
BioNTech Strives to Become Commercial ‘Powerhouse’ While
1 day ago · BioNTech partnered with Pfizer to produce the COVID-19 vaccine during the pandemic, a relationship that is ongoing. Hanekamp wouldn’t rule out any kind of partnership but said it will depend on the asset and whether it can be successful with BioNTech alone or with another company involved. Hanekamp said her JPM schedule is chock full of ...
BioNTech Announces Positive Topline Phase 2 Results for mRNA ...
Jul 30, 2024 · Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. BioNTech exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals.
BioNTech Provides Business and Pipeline Updates at 43rd Annual …
3 days ago · BioNTech aims to develop BNT327/PM8002 as a next-generation immuno-oncology (“IO”) backbone for the Company’s combination strategy targeting a broad range of indications;
BioNTech Positioned For Solid Growth Amid Oncology Transition: …
Jan 10, 2025 · BioNTech is transitioning from a COVID-focused narrative to a story centered on oncology drug development and upcoming catalysts. The analyst, Asthika Goonewardene, writes that BNT327 is at the ...
BioNTech Clinical Trials | Advancing Health Through Innovation
At BioNTech, we are committed to improving the health of people worldwide by developing novel medicines to address cancer, infectious diseases and other serious diseases. Clinical trials are vital in that mission. We invite volunteers, patients, and caregivers to learn more about how clinical trials work and how to participate in clinical ...
- Some results have been removed